Patents by Inventor Wado Akamatsu

Wado Akamatsu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200318064
    Abstract: Provided is an agent for accelerating maturation or aging of cells. An agent for accelerating maturation or aging of cells, comprising KU-60019 as an active ingredient.
    Type: Application
    Filed: October 11, 2019
    Publication date: October 8, 2020
    Applicant: JUNTENDO EDUCATIONAL FOUNDATION
    Inventors: Wado AKAMATSU, Takahiro Shiga, Naoko Kuzumaki, Hideyuki Okano
  • Publication number: 20200299643
    Abstract: A culture medium for inducing a pluripotent stem cell into a differentiation-promoted pluripotent stem cell, the medium including a Glycogen synthase kinase 3? (GSK3?) inhibitor, a Bone morphogenic protein (BMP) signaling inhibitor, and a Transforming growth factor (TGF)-? inhibitor as active ingredients.
    Type: Application
    Filed: March 27, 2017
    Publication date: September 24, 2020
    Inventors: Hideyuki OKANO, Wado AKAMATSU, Koki FUJIMORI, Takuya MATSUMOTO, Naoko KUZUMAKI, Fumihiko KISA
  • Publication number: 20190153387
    Abstract: A method is provided for uniformly differentiating a pluripotent stem cell into a neural stem cell, with elimination of variation among cell strains or clones of the pluripotent stem cell and without formation of an embryoid body, regardless of the origin of the pluripotent stem cell
    Type: Application
    Filed: February 14, 2017
    Publication date: May 23, 2019
    Inventors: Hideyuki OKANO, Wado AKAMATSU, Koki FUJIMORI, Tomoko NODA, Takayuki ANDOH, Toshiki TEZUKA, Takuya MATSUMOTO
  • Patent number: 9399759
    Abstract: In order to provide a method for producing neural stem cells easily and quickly by inducing differentiation of somatic cells directly into neurospheres, dedifferentiation factors are introduced into somatic cells, which are then cultured in suspension in the presence of growth factors to produce the neurospheres, thereby allowing the neural stem cells to be produced quickly without establishing iPS cells.
    Type: Grant
    Filed: November 4, 2009
    Date of Patent: July 26, 2016
    Assignee: Keio University
    Inventors: Wado Akamatsu, Hideyuki Okano
  • Publication number: 20110250684
    Abstract: In order to provide a method for producing neural stem cells easily and quickly by inducing differentiation of somatic cells directly into neurospheres, dedifferentiation factors are introduced into somatic cells, which are then cultured in suspension in the presence of growth factors to produce the neurospheres, thereby allowing the neural stem cells to be produced quickly without establishing iPS cells.
    Type: Application
    Filed: November 4, 2009
    Publication date: October 13, 2011
    Applicant: KEIO UNIVERSITY
    Inventors: Wado Akamatsu, Hideyuki Okano
  • Publication number: 20070299031
    Abstract: The present invention is directed to a therapeutic agent for a tumor of neural origin, containing, as an active ingredient, any of the following: Hu protein; a polypeptide having an amino acid sequence derived from an amino acid sequence of Hu protein by substitution, deletion, addition, or insertion of one or more amino acid residues; or a gene encoding the amino acid sequence of Hu protein or the peptide. Thus, the present invention provides a novel method for treating neuroblastoma.
    Type: Application
    Filed: June 29, 2007
    Publication date: December 27, 2007
    Applicant: JAPAN SCIENCE AND TECHNOLOGY AGENCY
    Inventors: Hideyuki OKANO, Wado Akamatsu
  • Publication number: 20040147438
    Abstract: The present invention is directed to a therapeutic agent for a tumor of neural origin, containing, as an active ingredient, any of the following: Hu protein; a polypeptide having an amino acid sequence derived from an amino acid sequence of Hu protein by substitution, deletion, addition, or insertion of one or more amino acid residues; or a gene encoding the amino acid sequence of Hu protein or the peptide. Thus, the present invention provides a novel method for treating neuroblastoma.
    Type: Application
    Filed: November 24, 2003
    Publication date: July 29, 2004
    Inventors: Hideyuki Okano, Wado Akamatsu